2 years ago
December 11, 2019
Summa Linguae Closes Two Deals and Completes Majority Sale to Private Equity
On December 9, 2019, Poland-based language service provider (LSP) Summa Linguae Technologies (SLT) completed two North-American acquisitions, and simultaneously sold 51% of its shares to private equity.
SLT had already signed the first deal to acquire Canada-based LSP Globalme on November 16, 2019. At the time, the deal closing date was scheduled for December 9, 2019 to coincide with SLT’s second acquisition and its majority sale to private equity firm V4C. Completing both acquisitions was a precondition of sale to V4C.
As planned, SLT has now completed its second acquisition, US-based life sciences LSP GlobalVision, and has become a portfolio company of V4C.
SLT CEO Krzysztof Zdanowski told Slator that GlobalVision will achieve revenues of USD 2m in 2019. With SLT paying USD 2.5m for GlobalVision, valuation was at 1.25x revenues.
According to Zdanowski, the rationale for the GlobalVision acquisition was threefold: the company’s strategic location in Boston, its focus on medical devices, and its strong Middle Eastern language coverage.
SLT’s new majority owner, V4C, paid around USD 14.6m for a 51% stake in SLT, equivalent to 8.4x EBITDA, Zdanowski said. He added that SLT’s post-money valuation is around USD 28.4m. Funds resulting from the sale will be used for, among other things, financing the Globalme and GlobalVision acquisitions.
Prior to the sale, SLT was listed on alternative stock exchange NewConnect in Warsaw, Poland. CEO Zdanowski and COO Madhuri Hegde were both material shareholders in SLT. V4C Partner Piotr Misztal led the deal along with Rafał Ałasa, Piotr Raczkowiak, and Bill Watson.
V4C was advised by Deloitte Legal in Warsaw, Deloitte Financial Advisory, and Deloitte Tax. SLT was advised by EY Corporate Finance and CK Legal Chabasiewicz Kowalska i Partnerzy.